Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)Panagiota Economopoulou, Amanda Psyrri, Aris Spathis et al.|Cancers|2021Cited by 29
Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).Panagiota Economopoulou, Amanda Psyrri, Nikolaos Spathas et al.|Journal of Clinical Oncology|2019Cited by 4